RCA Locus Analysis to Assess Susceptibility to AMD and MPGNII

The invention relates to gene polymorphisms and genetic profiles associated with an elevated or a reduced risk of alternative complement cascade deregulation disease such as AMD and/or MPGNII. The invention provides methods and reagents for determination of risk, diagnosis and treatment of such diseases. In an embodiment, the present invention provides methods and reagents for determining sequence variants in the genome of a individual which facilitate assessment of risk for developing such diseases.

Patents:
WO 2,009,059,321   [MORE INFO]

Inventor(s): HAGEMAN GREGORY S [US]

Type of Offer: Licensing



« More Medical Patents

---